9-MTH group results (IFRS)

Nxera Pharma

11/11/2020 06:30

Nov 11 (Reuters)- 
              Sosei Group Corp 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   9 months ended      9 months ended       Year to 
                  Sep 30, 2020        Sep 30, 2019     Dec 31, 2020 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales               4.44                7.77                      
                   (-42.8 pct)        (+170.5 pct)                  
  Operating         loss 1.22             1.09                      
  Pretax            loss 1.48             1.14                      
  Net               loss 1.64             1.46                      
  EPS Basic      loss 21.03 yen         19.11 yen                   
  EPS Diluted    loss 21.03 yen         18.91 yen                   
  Ann Div                                  NIL              NIL     
  -Q2 Div              NIL                 NIL                      
  -Q4 Div                                  NIL              NIL     
 
  NOTE - Sosei Group Corp. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4565.T